SEC Form 4 · accession 0001161697-15-000101
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J McEnany
Officer — President and CEO · Director
Period of report
Feb 25, 2015
Accepted (ET)
Feb 27, 2015 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1 | Feb 25, 2015 | M | 364,804 | $0.685 | A | 4,189,801 | D | |
| Common stock, par value $0.001 per shareF1 | Feb 25, 2015 | F | 67,539 | — | D | 4,122,262 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stockF1 | $0.685 | Feb 25, 2015 | M | 364,804 | D | Mar 4, 2005 | Mar 4, 2015 | Common Stock | 364,804 | 786,250 | D |
Explanation of responses
- F1Holder exercised 364,804 options at $0.685 per share on a cashless basis and was issued 297,265 shares based on the February 25, 2015 closing price of $3.70 per share.